Our competitor is in the NDA with Priority Review:
FDA ADCOMM VOTE: Has the Applicant (Levo Therapeutics) provided substantial evidence of effectiveness for carbetocin nasal spray (LV-101) in the treatment of hyperphagia associated with Prader Willi syndrome? 1-Yes 12-No 0-Abstain
Ann: FDA grants Orphan Drug designation for Prader-Willi syndrome, page-21
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.26 |
Change
-0.280(2.23%) |
Mkt cap ! $1.522B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $3.504M | 289.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 31 | $12.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.28 | 470 | 4 |
View Market Depth
| Last trade - 13.06pm 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |